Src family kinases are best known for their role in malignant transformation and tumor progression, as well as signaling through cell surface integrins ([@bib64]; [@bib67]). Due to their role in cancer development and progression, Src family kinases have become major targets of cancer therapy ([@bib34]; [@bib91]). Src family kinases are also present in immune cells with dominant expression of Lck and Fyn in T cells and NK cells; Lyn, Fyn, and Blk in B cells and mast cells; and Hck, Fgr, and Lyn in myeloid cells such as neutrophils and macrophages ([@bib42]).

The best known function of Src family kinases in the immune system is their role in integrin signal transduction. Indeed, Hck, Fgr, and Lyn mediate outside-in signaling by β~1~ and β~2~ integrins in neutrophils and macrophages ([@bib45]; [@bib46]; [@bib48]; [@bib79]; [@bib65]; [@bib20]; [@bib26]), Lck participates in LFA-1--mediated T cell responses ([@bib55]; [@bib13]; [@bib15]; [@bib80]), and Src family kinases are required for LFA-1--mediated signal transduction and target cell killing by NK cells ([@bib68]; [@bib66]).

Src family kinases also mediate TCR signal transduction by phosphorylating the TCR-associated immunoreceptor tyrosine-based activation motifs (ITAMs), leading to recruitment and activation of ZAP-70 ([@bib83]; [@bib90]; [@bib62]). However, their role in receptor-proximal signaling by the BCR and Fc receptors is rather controversial. Although the combined deficiency of Lyn, Fyn, and Blk results in defective BCR-induced NF-κB activation, receptor-proximal BCR signaling (ITAM phosphorylation) is not affected ([@bib71]). Genetic deficiency of Lyn, the predominant Src family kinase in B cells, even leads to enhanced BCR signaling and B cell--mediated autoimmunity ([@bib25]; [@bib59]; [@bib3]). Similarly, both positive ([@bib25]; [@bib58]; [@bib63]; [@bib21]; [@bib14]) and negative ([@bib31]; [@bib24]; [@bib61]; [@bib21]; [@bib14]) functions for Fyn and Lyn during Fc receptor signaling in mast cells have been reported. In addition, Hck^−/−^Fgr^−/−^ neutrophils respond normally to IgG immune complex--induced activation ([@bib45]) and Fc receptor--mediated phagocytosis of IgG-coated red blood cells is delayed but not blocked in Hck^−/−^Fgr^−/−^Lyn^−/−^ macrophages ([@bib17]; [@bib42]). The differential requirement for Src family kinases in TCR, BCR, and Fc receptor signaling is thought to derive from the fact that Syk, but not ZAP-70, is itself able to phosphorylate ITAM tyrosines ([@bib69]), making Src family kinases indispensable for signaling by the ZAP-70--coupled TCR but not by the Syk-coupled BCR and Fc receptors.

Autoantibody production and immune complex formation is one of the major mechanisms of autoimmunity-induced tissue damage. In vivo models of those processes include the K/B×N serum transfer arthritis ([@bib35]) and autoantibody-induced blistering skin diseases ([@bib39]; [@bib76], [@bib77]), which mimic important aspects of human rheumatoid arthritis, bullous pemphigoid, and epidermolysis bullosa acquisita. Activation of neutrophils or macrophages ([@bib40]; [@bib87]; [@bib76], [@bib77]; [@bib78]), recognition of immune complexes by Fcγ receptors ([@bib30]; [@bib76], [@bib77]), and β~2~ integrin--mediated leukocyte recruitment ([@bib86]; [@bib41]; [@bib7]; [@bib54]; [@bib56]) are indispensable for the development of those in vivo animal models.

The role of Src family kinases in β~2~ integrin signaling and the requirement for β~2~ integrins during autoantibody-induced in vivo inflammation prompted us to test the role of Src family kinases in autoantibody-induced inflammatory disease models. We found that Hck^−/−^Fgr^−/−^Lyn^−/−^ mice were completely protected from autoantibody-induced arthritis and inflammatory blistering skin disease. Surprisingly, this was not due to a cell-autonomous defect in β~2~ integrin--mediated leukocyte migration but to defective generation of an inflammatory microenvironment, likely due to the role of Src family kinases in immune complex--induced neutrophil and macrophage activation.

RESULTS
=======

Hck, Fgr, and/or Lyn are required for autoantibody-induced arthritis
--------------------------------------------------------------------

To determine the role of Src family kinases in autoantibody-induced arthritis, we first tested the development of K/B×N serum transfer arthritis in Hck^−/−^Fgr^−/−^Lyn^−/−^ triple knockout mice. As shown in [Fig. 1 A](#fig1){ref-type="fig"}, administration of arthritogenic (K/B×N) serum triggered robust arthritis in WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ animals. The Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation completely protected mice from disease development both in terms of visible clinical signs ([Fig. 1 B](#fig1){ref-type="fig"}; P = 4.2 × 10^−5^; *n* = 6) and ankle thickening ([Fig. 1 C](#fig1){ref-type="fig"}; P = 4.5 × 10^−4^; *n* = 6). We also tested the ability of the mice to hold onto the lower side of a wire grid as a measure of joint function ([@bib29]). Although the majority of arthritic serum-treated WT mice fell off the grid within a few seconds, most of the Hck^−/−^Fgr^−/−^Lyn^−/−^ were able to hold onto the grid throughout the entire 20-second assay period ([Fig. 1 D](#fig1){ref-type="fig"}; P = 9.5 × 10^−6^; *n* = 6).

![**Myeloid Src family kinases are indispensable for autoantibody-induced arthritis.** Intact (A--D) WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) mice or bone marrow chimeras (E--H) generated by transplanting WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ bone marrow to WT (WT►WT and 3× SFK KO►WT, respectively) or Hck^−/−^Fgr^−/−^Lyn^−/−^ recipients (WT►3× SFK KO) were injected with B×N (control) or K/B×N (arthritic) serum i.p. on day 0. Arthritis development was followed by photographing on day 8 (A and E), clinical scoring of the hind limbs (B and F), ankle thickness measurement (C and G) and an articular function test (hanging on a wire grid; D and H). Images are representative of, and quantitative data show mean and SEM from, 4 control and 6 arthritic serum-treated individual mice per group from 2 independent experiments (A--D) or 4--12 control and 7--26 arthritic serum-treated mice per group from 2--8 independent experiments (E--H). D and H show results from functional test performed 6--21 times on each mouse between days 6--12.](JEM_20132496_Fig1){#fig1}

We also performed arthritis experiments in bone marrow chimeras generated by transplanting Hck^−/−^Fgr^−/−^Lyn^−/−^ bone marrow cells to WT recipients or vice versa. As shown in [Fig. 1 (E--H)](#fig1){ref-type="fig"}, bone marrow chimeras carrying Hck^−/−^Fgr^−/−^Lyn^−/−^ bone marrow cells in a WT recipient were completely protected from all signs of K/B×N serum transfer arthritis (P = 2.0 × 10^−12^, 3.5 × 10^−11^, and 1.2 × 10^−7^ for clinical score, ankle thickness, and joint functional assay, respectively; *n* = 14--21), whereas Hck^−/−^Fgr^−/−^Lyn^−/−^ mice transplanted with WT bone marrow cells showed a normal disease course and an even somewhat more severe functional defect (P = 0.36, 0.59, and 0.028, respectively; *n* = 7). The above results indicate that expression of Hck, Fgr, and/or Lyn in the hematopoietic compartment is indispensable for the development of autoantibody-induced arthritis in experimental mice.

Overlapping role of Hck, Fgr, and Lyn during autoantibody-induced arthritis
---------------------------------------------------------------------------

We next tested K/B×N serum transfer arthritis in bone marrow chimeras with single or double deficiency of Hck, Fgr, or Lyn in the hematopoietic compartment. Representative hind limb images are shown in [Fig. 2 A](#fig2){ref-type="fig"}, quantitative analyses of arthritic serum-treated mice in [Fig. 2 (B--D)](#fig2){ref-type="fig"}, and cumulated data for both control and arthritic serum-treated mice in [Fig. 2 (E--G)](#fig2){ref-type="fig"}. Hck, Fgr, or Lyn single deficiency did not affect arthritis development in our model (p-values for clinical score, ankle thickness, and joint functional test were between 0.34 and 0.98; *n* = 10--11). Hck^−/−^Fgr^−/−^ and Fgr^−/−^Lyn^−/−^ double knockout chimeras showed no protection either (0.086 ≤ P ≤ 0.99; *n* = 4--10). The Hck^−/−^Lyn^−/−^ double mutation caused substantial but incomplete reduction of arthritis development (P = 1.2 × 10^−10^, 1.4 × 10^−9^, and 0.031 for clinical score, ankle thickness, and joint functional test, respectively; *n* = 5--7); however, the poor overall health status of these chimeras ([@bib88]) may have affected their response in our model. Importantly, complete protection from arthritis development was only seen in the absence of all three kinases (P = 2.0 × 10^−12^, 3.5 × 10^−11^, and 1.2 × 10^−7^, respectively; *n* = 14--21), indicating significant functional overlap between Hck, Fgr, and Lyn during autoantibody-induced inflammation.

![**Overlapping role of Hck, Fgr, and Lyn during autoantibody-induced arthritis.** (A) Arthritis was induced and assessed in WT, Hck^−/−^, Fgr^−/−^, and Lyn^−/−^ single, Hck^−/−^Fgr^−/−^, Hck^−/−^Lyn^−/−^, and Fgr^−/−^Lyn^−/−^ double, and Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) triple knockout bone marrow chimeric mice as described in the [Fig. 1](#fig1){ref-type="fig"} legend. Controls for all genotypes were combined in B--D. E--G show cumulative data obtained from the experiments shown in B--D. Images are representative of, and quantitative data show mean and SEM from 1--12 control and 7--26 arthritic serum-treated mice per genotype from 10 independent experiments. The joint functional test (D and G) were performed 3--24 times on each mouse between days 6 and 12. The WT and Hck^−/−^Fgr^−/−^Lyn^−/−^ chimeric data include results presented in [Fig. 1 (E--H)](#fig1){ref-type="fig"}. AUC, area under the curve.](JEM_20132496_Fig2){#fig2}

Other immune complex--induced inflammation models
-------------------------------------------------

We also tested the effect of the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation on other autoantibody-induced inflammatory processes. Systemic administration of collagen VII--specific antibodies (a mouse model of the human blistering skin disease epidermolysis bullosa acquisita; [@bib77], [@bib75]) triggered skin inflammation in WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ mutant animals ([Fig. 3 A](#fig3){ref-type="fig"}). Hck^−/−^Fgr^−/−^Lyn^−/−^ mutants were completely protected both in terms of the body surface area affected ([Fig. 3 B](#fig3){ref-type="fig"}; P = 1.5 × 10^−10^; *n* = 11) and the overall disease severity ([Fig. 3 C](#fig3){ref-type="fig"}; P = 1.1 × 10^−10^; *n* = 13). However, circulating collagen VII--specific antibody titers were not affected by the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation ([Fig. 3 D](#fig3){ref-type="fig"}; P = 0.34; *n* = 2). Importantly, intact Hck^−/−^Fgr^−/−^Lyn^−/−^ mice and Hck^−/−^Fgr^−/−^Lyn^−/−^ bone marrow chimeras were both completely protected from skin disease in our model (unpublished data).

![**Src family kinases in autoantibody-induced skin blistering disease and the reverse passive Arthus reaction.** (A--D) Blistering skin disease was triggered in WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) mice or bone marrow chimeras by systemic injection of collagen VII--specific (α-CVII) antibodies. Skin disease was followed by photographing on day 14 (A) and clinical assessment of the total body surface affected (B) and the overall disease severity (C). The serum titer of α-CVII antibodies was tested on day 6 by ELISA (D). Representative images (A) or mean and SEM (B--D) from 5--7 control (1 intact and 4--6 bone marrow chimeric) and 13--14 α-CVII--treated (4 intact and 9--10 bone marrow chimeric) mice per genotype from 4 independent experiments are shown. No difference between intact and chimeric mice of the same hematopoietic genotype was observed (not depicted). (E and F) Reverse passive Arthus reaction was triggered in intact WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) mice by systemic administration of ovalbumin, followed by intradermal injection of normal (control) or anti-ovalbumin (anti-Ova) rabbit serum into the left and right ears, respectively. Edema formation was assessed by determining the accumulation of radioactively labeled albumin from the circulation by NanoSPECT with a reference CT scan. Representative images (E) and mean and SEM (F) from 4--8 mice per genotype from 3 independent experiments are shown.](JEM_20132496_Fig3){#fig3}

We also tested the reverse passive Arthus reaction triggered by systemic administration of ovalbumin followed by intradermal injection of anti-ovalbumin into the ear. Edema formation was followed by imaging the accumulation of radioactively labeled albumin from the circulation. As shown in [Fig. 3 (E and F)](#fig3){ref-type="fig"}, anti-ovalbumin injection caused robust increase of vascular permeability in WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ animals (P = 0.013; *n* = 8). Collectively, Hck, Fgr, and Lyn are required for antibody-induced tissue damage in various in vivo inflammation models.

Myeloid cells fail to accumulate at the site of inflammation
------------------------------------------------------------

We and others reported complete protection of CD18^−/−^ mice from K/B×N serum transfer arthritis, likely due to a cell-autonomous role for LFA-1 in migration of myeloid cells to the site of inflammation ([@bib86]; [@bib56]; [@bib54]). Given the role for Src family kinases in integrin signaling in myeloid cells and in autoantibody-induced in vivo inflammation ([Figs. 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}), we next tested their role in leukocyte accumulation at the inflammatory site. As shown in [Fig. 4 A](#fig4){ref-type="fig"}, K/B×N serum transfer arthritis triggered robust leukocytic infiltration of the synovial area of WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ mice. Flow cytometric analysis revealed a dramatic increase of neutrophil numbers in the synovial tissue of arthritic serum-treated WT mice that was entirely dependent on CD18 ([Fig. 4 B](#fig4){ref-type="fig"}; P = 6.8 × 10^−5^ and 1.6 × 10^−4^ for ankle and front limb, respectively; *n* = 5). Importantly, the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation also abrogated neutrophil infiltration at the synovial area ([Fig. 4 B](#fig4){ref-type="fig"}; P = 7.2 × 10^−5^ and 1.7 × 10^−4^, respectively; *n* = 13). The defective neutrophil infiltration was not due to reduced circulating numbers of neutrophils because blood neutrophil counts were even higher in both CD18^−/−^ (10.7 ± 2.1 and 16.9 ± 5.7 thousand cells/µl before and on day 4 after K/B×N serum transfer, respectively; *n* = 4) and Hck^−/−^Fgr^−/−^Lyn^−/−^ (2.5 ± 0.6 and 4.6 ± 1.6 thousand cells/µl, respectively; *n* = 4) than in WT animals (0.6 ± 0.1 and 1.4 ± 0.3 thousand cells/µl, respectively; *n* = 4).

![**Myeloid cells fail to accumulate at the site of inflammation.** Intact WT, CD18^−/−^ (CD18 KO), or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) mice were subjected to K/B×N serum transfer arthritis (A, B, D, and E) or autoantibody-induced skin blistering disease (C) as described in the legends to [Figs. 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}. (A) Hematoxylin-eosin--stained sections of ankle joints 7 d after the serum transfer. Images are representative of 4 control and 6 arthritic serum-treated mice per genotype from 2 independent experiments. Lower images were magnified from the upper sections. Bars, 200 µm. (B--D) The ankle area or the front paw was flushed (B, D, and E) or the nasal skin was digested (C), and the number of neutrophils (PMN; B and C) or monocytes/macrophages (mono/MΦ; D and E) was determined by flow cytometry. Graphs represent mean and SEM of data obtained from 3--7 control and 5--13 arthritic serum-treated mice per genotype from 2--5 independent experiments (B and D), 3--4 control and 6 arthritic serum-treated mice per genotype from 2 independent experiments (E), or 2 control and 4 anti-CVII--treated mice per genotype from 2 independent experiments (C). a., ankle; f., front paw.](JEM_20132496_Fig4){#fig4}

We also tested neutrophil infiltration in the nasal skin during autoantibody-induced skin blistering disease. As shown in [Fig. 4 C](#fig4){ref-type="fig"}, neutrophils infiltrated the skin of WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ animals (P = 0.0088; *n* = 4).

We next tested the accumulation of monocytes/macrophages. Ly6G^−^F4/80^+^ cells infiltrated the synovial area of arthritic serum-treated WT mice, and this was again entirely dependent on the presence of CD18 ([Fig. 4 D](#fig4){ref-type="fig"}; P = 1.1 × 10^−4^ and 1.6 × 10^−4^ for ankle and front paw, respectively; *n* = 5). The Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation also completely abrogated the accumulation of Ly6G^−^F4/80^+^ cells ([Fig. 4 D](#fig4){ref-type="fig"}; P = 1.1 × 10^−4^ and 1.7 × 10^−4^, respectively; *n* = 13). Again, the defective infiltration was not due to reduced number of circulating monocytes because Ly6G^−^F4/80^+^ blood monocyte counts in CD18^−/−^ (710 ± 144 and 1,591 ± 351 cells/µl on days 0 and 4, respectively; *n* = 4) and Hck^−/−^Fgr^−/−^Lyn^−/−^ mice (553 ± 154 and 244 ± 59 cells/µl, respectively; *n* = 4) was similar to or higher than those in WT animals (433 ± 90 and 258 ± 40 cells/µl, respectively; *n* = 4). No infiltration of monocytes/macrophages identified as Ly6G^−^CD11b^+^ cells could be observed in the synovial area of Hck^−/−^Fgr^−/−^Lyn^−/−^ mice either ([Fig. 4 E](#fig4){ref-type="fig"}; P = 0.015 and 0.031 for ankle and front paw, respectively; *n* = 6; this could not be tested in CD18^−/−^ mice because their leukocytes do not express CD11b). Collectively, similar to the CD18 deficiency, the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation also abrogates the accumulation of myeloid cells at the site of inflammation.

No cell-autonomous migration defect in Hck^−/−^Fgr^−/−^Lyn^−/−^ myeloid cells
-----------------------------------------------------------------------------

To reveal whether the defective leukocyte recruitment in Hck^−/−^Fgr^−/−^Lyn^−/−^ mice is due to a cell-autonomous migration defect, we directly compared the accumulation of WT and mutant cells within the same animal. To this end, we generated mixed bone marrow chimeras carrying varying ratios of CD45.1-expressing WT, along with CD45.2-positive WT, CD18^−/−^, or Hck^−/−^Fgr^−/−^Lyn^−/−^ hematopoietic cells within the same animal (WT:WT, WT:CD18^−/−^, and WT:Hck^−/−^Fgr^−/−^Lyn^−/−^ chimeras, respectively). We then compared the percentage of CD45.2-positive cells in the blood and synovial tissue within the same individual mouse during K/B×N serum transfer arthritis.

In chimeras having CD45.2-expressing WT and CD45.1-expressing WT hematopoietic tissues (WT:WT chimeras), the percentage of CD45.2-positive neutrophils was similar in the blood and synovial infiltrate in all chimeras tested ([Fig. 5 A](#fig5){ref-type="fig"}). In contrast, in WT:CD18^−/−^ chimeras ([Fig. 5 B](#fig5){ref-type="fig"}), the percentage of CD45.2-expressing (i.e., CD18^−/−^) neutrophils in the inflamed synovium was much lower than that in the circulation, indicating a cell-autonomous recruitment defect of CD18^−/−^ neutrophils. Surprisingly, in WT:Hck^−/−^Fgr^−/−^Lyn^−/−^ chimeras ([Fig. 5 C](#fig5){ref-type="fig"}), no difference between the percentage of CD45.2-positive (i.e., Hck^−/−^Fgr^−/−^Lyn^−/−^) neutrophils in the blood and the synovial infiltrate could be observed, indicating that Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils can accumulate normally at the site of inflammation when WT cells are also present in the same animal. The results of such experiments performed on a large cohort of mice are summarized in [Fig. 5 D](#fig5){ref-type="fig"}, where each dot represents an individual mouse. Although dots of WT:WT and WT:Hck^−/−^Fgr^−/−^Lyn^−/−^ chimeras line up along the dotted line representing equal ratios in the blood and the synovium, dots of WT:CD18^−/−^ chimeras are shifted to the lower right, indicating reduced ability of CD18^−/−^ cells to enter the synovium from the circulation. The same data have also been used to calculate the relative migratory capacity of neutrophils of the different genotypes ([Fig. 5 F](#fig5){ref-type="fig"}). Those calculations confirmed a strong cell-autonomous recruitment defect of CD18^−/−^ neutrophils (P = 2.0 × 10^−12^ and 1.0 × 10^−9^ for ankle and front paw, respectively; *n* = 10--14), whereas the accumulation of Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils was even slightly higher (P = 0.021 and 0.11, respectively; *n* = 7--15) than that of WT cells within the same animal.

![**Normal in vitro and in vivo migration of Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils.** (A--G) Mixed bone marrow chimeras with CD45.1-expressing WT and CD45.2-expressing WT, CD18^−/−^ (CD18 KO), or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) hematopoietic cells were subjected to K/B×N serum transfer arthritis as described in the [Fig. 1](#fig1){ref-type="fig"} legend. In vivo accumulation of neutrophils (PMN; A--D and F) and monocytes/macrophages (Mono/MΦ; E and G) was determined by flushing the synovial area of arthritic serum-treated mixed bone marrow chimeras on day 4, followed by flow cytometric analysis of the ratio of CD45.1- and CD45.2-expressing cells in peripheral blood and the synovial infiltrate. A--C shows representative histograms of CD45.2 expression in blood or synovial neutrophils. In D and E, each dot represents an individual mouse. Bar graphs in F and G show mean and SEM of relative migration. Data are representative of (A--C) or summarize (D and F) data obtained from 7--26 mice per group from 3--9 independent experiments or 7--14 mice per group from 3--5 independent experiments (E and G). (H and I) In vitro migration of CD18^−/−^ and Hck^−/−^Fgr^−/−^Lyn^−/−^ bone marrow neutrophils (H) and monocytes (I) toward the indicated chemoattractants in a fibrinogen-coated Transwell system. Data represent mean and SEM of 3--13 (H) or 3--5 (I) independent experiments.](JEM_20132496_Fig5){#fig5}

We have also tested the accumulation of monocytes/macrophages in a similar manner. As shown in [Fig. 5 (E and G)](#fig5){ref-type="fig"}, although CD18 deficiency caused a significant cell-autonomous reduction of the percentage of Ly6G^−^F4/80^+^ macrophages in the synovial tissue (relative to the percentage of CD18^−/−^ cells among circulating Ly6G^−^F4/80^+^ monocytes; P = 8.0 × 10^−6^; *n* = 7), the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation did not affect the accumulation of F4/80-positive cells in the inflamed synovium (P = 0.83; *n* = 5). The Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation had no effect on macrophage accumulation when the cells were identified as Ly6G^−^CD11b^+^ cells either ([Fig. 5, E and G](#fig5){ref-type="fig"}; P = 0.37; *n* = 6). Collectively, when WT cells are present in mixed bone marrow chimeras, Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils and monocytes/macrophages accumulate normally at the site of inflammation, arguing against a cell-autonomous migration defect of Hck^−/−^Fgr^−/−^Lyn^−/−^ myeloid cells.

Normal in vitro migration of Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils and monocytes
-------------------------------------------------------------------------------

We next tested the migration of neutrophils and monocytes in an in vitro Transwell assay. As shown in [Fig. 5 H](#fig5){ref-type="fig"}, neutrophil migration toward fMLP (which mimics bacterial/mitochondrial-derived signals) was strongly reduced in CD18^−/−^ (P = 4.1 × 10^−4^; *n* = 4) but not in Hck^−/−^Fgr^−/−^Lyn^−/−^ cells (P = 0.17; *n* = 4). Similarly, neutrophil migration toward the lipid chemoattractant LTB~4~ was dependent on CD18 (P = 1.7 × 10^−6^; *n* = 3) but was not affected by the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation (P = 0.41; *n* = 4). Interestingly, migration of neutrophils toward macrophage inflammatory protein 2 (MIP-2; CXCL2), a distant homologue of human IL-8, was not affected by either the CD18^−/−^ (P = 0.58; *n* = 9) or the Hck^−/−^Fgr^−/−^Lyn^−/−^ (P = 0.39; *n* = 7) mutation.

We have also tested the in vitro migration of freshly isolated bone marrow monocytes ([Fig. 5 I](#fig5){ref-type="fig"}). Monocyte migration toward leukotriene B~4~ (LTB~4~) was abrogated by CD18 deficiency (P = 0.0038; *n* = 3) but not by the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation (P = 0.93; *n* = 5). Migration of monocytes toward MIP-1α (CCL3), one of the major monocyte chemoattractants, was also moderately reduced by the CD18^−/−^ mutation with a borderline statistical significance (P = 0.057; *n* = 3), but it was normal in Hck^−/−^Fgr^−/−^Lyn^−/−^ cells (P = 0.63; *n* = 5). The migration of the cells toward monocyte chemoattractant protein 1 (MCP-1; CCL2), another major monocyte chemoattractant, was slightly even increased by CD18 deficiency (P = 0.0039; *n* = 3), but it was not affected by the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation (P = 0.74; *n* = 5). Collectively, in vitro migration of neutrophils and monocytes toward major proinflammatory chemoattractants does not depend on Hck, Fgr, or Lyn irrespective of the requirement for β~2~ integrins in the given assay.

Defective generation of the inflammatory environment
----------------------------------------------------

The above observations could be explained by a role for myeloid Src family kinases in the generation of the inflammatory environment. As shown in the cytokine arrays in [Fig. 6 A](#fig6){ref-type="fig"} (see array map in [Fig. 6 B](#fig6){ref-type="fig"} and quantification in [Table S1](http://www.jem.org/cgi/content/full/jem.20132496/DC1){#supp1}), K/B×N serum transfer arthritis triggered robust accumulation of various inflammatory mediators in the synovial tissue of WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ animals. Prior studies suggested important roles for IL-1β, keratinocyte chemoattractant (KC; CXCL1), MIP-1α, MIP-2, and LTB~4~ in myeloid cell infiltration during autoantibody-induced inflammation ([@bib33]; [@bib8]; [@bib27]), whereas MCP-1 is considered a major monocyte chemoattractant ([@bib12]). ELISA assays ([Fig. 6 C](#fig6){ref-type="fig"}) confirmed that the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation abrogated the up-regulation of IL-1β (P = 0.0026; *n* = 5), KC (P = 9.0 × 10^−7^; *n* = 5), MCP-1 (P = 0.0014; *n* = 5), MIP-2 (P = 0.023; *n* = 6), and LTB~4~ (P = 7.4 × 10^−15^; *n* = 3) in the synovial tissue and caused a substantial (though not statistically significant) reduction of MIP-1α levels (P = 0.095; *n* = 4).

![**Myeloid Src family kinases are required for the generation of an inflammatory environment in vivo.** Intact WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) mice were subjected to K/B×N serum transfer arthritis as described in the legend to [Fig. 1](#fig1){ref-type="fig"}. (A and C) The synovial area was flushed on Day 4. The cell-free supernatants of the synovial infiltrates were probed using a commercial cytokine array (A) or by ELISA assays for the indicated pro-inflammatory mediators (C). (B) Map of the position of the different analytes on the cytokine array. A shows representative images from 2 independent experiments, whereas C shows mean and SEM of 4--6 mice per group from 3--5 independent experiments. (D-E) MPO activity was determined in vivo by chemiluminescence imaging after i.p. injection of luminol. Color-coded photon flux intensity is superposed on the grayscale photo of the mouse (D) and quantitated in defined regions of interest (E). Representative images (D) and mean and SEM (E) from 4 control and 6 arthritic serum-treated mice per genotype from 2 independent experiments are shown.](JEM_20132496_Fig6){#fig6}

We have also tested the generation of reactive oxygen species (ROS) and the release of granule enzymes into the extracellular space at the inflammatory site by in vivo imaging of the activity of myeloperoxidase (MPO), a neutrophil granule-derived ROS-producing enzyme ([@bib22]; [@bib60]). As shown in [Fig. 6 (D and E)](#fig6){ref-type="fig"}, K/B×N serum transfer arthritis triggered a robust ROS bioluminescence signal localized to the ankles and front paws in WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ mutant animals (P = 0.010; *n* = 6). Collectively, myeloid Src family kinases are required for various aspects of the generation of a proinflammatory environment during autoantibody-induced arthritis.

Hck^−/−^Fgr^−/−^Lyn^−/−^ myeloid cells fail to respond to immune complex stimulation
------------------------------------------------------------------------------------

To test whether Src family kinases are directly involved in the generation of an inflammatory environment, we investigated immune complex--induced in vitro responses of neutrophils and macrophages. As shown in [Fig. 7 (A and B)](#fig7){ref-type="fig"}, the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation completely blocked immune complex--induced superoxide release from neutrophils (P = 2.4 × 10^−21^; *n* = 15). Similar to the in vivo findings with K/B×N serum transfer arthritis ([Fig. 2](#fig2){ref-type="fig"}), the Hck^−/−^Lyn^−/−^ mutation caused a partial but statistically significant reduction (P = 5.8 × 10^−4^; *n* = 4; this may in part be due to increased basal levels in those samples), whereas the other single or double knockouts had no significant defect ([Fig. 7, A and B](#fig7){ref-type="fig"}; 0.10 \< P \< 0.71; *n* = 3).

![**Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils fail to respond to immune complex stimulation.** WT, Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO), and the various single and double knockout neutrophils were placed on immobilized immune complex (IC) surfaces. Superoxide release (A and B) was followed by a spectrophotometric assay. Cytokine, chemokine, and lipid mediator levels in cell-free supernatants were determined after an incubation for 1 h (LTB~4~) or 6 h (all other readouts) using a commercial cytokine array (C) or ELISA assays (D). Graphs in A and B show mean and SEM of 3--22 independent experiments per genotype. Values at the zero time point were subtracted. C is representative of 2 independent experiments. D shows mean and SEM from 4--11 independent experiments.](JEM_20132496_Fig7){#fig7}

As shown in the cytokine arrays in [Fig. 7 C](#fig7){ref-type="fig"} (see array map in [Fig. 6 B](#fig6){ref-type="fig"} and quantification in Table S1), immune complex stimulation also triggered the release of several cytokines and chemokines from WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils. ELISA assays revealed that the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation dramatically reduced or even completely abrogated the immune complex--induced release of IL-1β (P = 5.1 × 10^−5^; *n* = 6), KC (P = 3.6 × 10^−5^; *n* = 6), MIP-1α (P = 5.0 × 10^−6^; *n* = 6), MIP-2 (P = 4.8 × 10^−15^; *n* = 11), and LTB~4~ (P = 8.8 × 10^−5^; *n* = 4) from neutrophils ([Fig. 7 D](#fig7){ref-type="fig"}), whereas no release of MCP-1 could be observed even from WT cells (not depicted).

We also tested the immune complex--induced responses of bone marrow--derived macrophages. As shown in [Fig. 8 A](#fig8){ref-type="fig"}, the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation completely blocked immune complex--induced ROS production by macrophages (P = 2.8 × 10^−8^; *n* = 4). The cytokine arrays shown in [Fig. 8 B](#fig8){ref-type="fig"} (see array map in [Fig. 6 B](#fig6){ref-type="fig"} and quantification in Table S1) indicated immune complex--induced release of various proinflammatory cytokines from WT macrophages which was strongly reduced in Hck^−/−^Fgr^−/−^Lyn^−/−^ cultures. ELISA assays ([Fig. 8 C](#fig8){ref-type="fig"}) confirmed that the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation strongly inhibited the immune complex--induced release of KC (P = 0.0013; *n* = 5), MCP-1 (P = 0.010; *n* = 4), and TNF (P = 4.0 × 10^−4^; *n* = 4) from macrophages, caused a partial but statistically significant inhibition of MIP-2 release (P = 0.027; *n* = 4), and led to an apparent reduction of MIP-1α release which, however, did not reach statistical significance (P = 0.29; *n* = 4). In contrast, no release of IL-1β or LTB~4~ could be observed even in WT cultures (unpublished data). Collectively, the genetic deficiency of Hck, Fgr, and Lyn blocks the immune complex--induced release of various components of the inflammatory environment from both neutrophils and macrophages.

![**Defective responses of Hck^−/−^Fgr^−/−^Lyn^−/−^ macrophages to immune complex stimulation.** Bone marrow--derived WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) macrophages were placed on immobilized immune complex (IC) surfaces. Their superoxide release (A) was followed by a luminometric assay. Cytokine and chemokine levels from the cell-free supernatants taken after 24 h were tested by a commercial cytokine array (B) or by ELISA assays (C). A shows mean and SEM from 4 independent experiments. B is representative of 2 experiments. C shows mean and SEM of data from 4--5 independent experiments.](JEM_20132496_Fig8){#fig8}

Src family kinases are required for initial Fc receptor signaling in neutrophils
--------------------------------------------------------------------------------

Prior studies indicated that Src family kinases are critically involved in integrin- but not Fc receptor--mediated functional responses of myeloid cells ([@bib45]; [@bib46]; [@bib48]; [@bib79]; [@bib17]; [@bib65]; [@bib42]). Our above observations led us to reevaluate this issue.

We first tested the phosphorylation of the Fc receptor γ-chain (FcRγ), the ITAM-containing signaling chain of activating Fc receptors. As shown in [Fig. 9 A](#fig9){ref-type="fig"}, a glutathione S-transferase (GST) fusion protein of the tandem SH2 domains of Syk (GST-Syk(SH2)~2~) was able to pull down FcRγ from lysates of immune complex--activated WT neutrophils, whereas no such signal could be observed upon functional disruption of both SH2 domains ([@bib53]), indicating that this assay specifically detects phosphorylation of the FcRγ ITAM tyrosines. Importantly, no FcRγ phosphorylation could be observed in lysates of immune complex--stimulated Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils ([Fig. 9 B](#fig9){ref-type="fig"}).

![**Src family kinases are required for immune complex--induced phosphorylation of FcRγ and Syk.** (A--C) WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ (3× SFK KO) neutrophils were plated on immobilized IgG immune complexes (IC). Cell lysates were subjected to a GST pulldown assay (A and B) using either WT or R41A/R194A double mutant (SH2-Dead) GST-Syk(SH2)~2~ fusion protein and probed for the presence of FcRγ by Western blotting (WB), or processed for Syk immunoprecipitation (IP), followed by immunoblotting for phosphotyrosine (PY) or Syk as a loading control (C). Whole cell lysates (WCL) served as loading control in A and B. Blots in A--C are representative of 3 independent experiments. Note substantial mobility shift caused by the tyrosine phosphorylation of FcRγ homodimers under the used nonreducing (NR) conditions in A and B. WB, Western blot.](JEM_20132496_Fig9){#fig9}

We next tested the activation of the Syk tyrosine kinase. As shown in [Fig. 9 C](#fig9){ref-type="fig"}, immune complex--induced neutrophil activation led to tyrosine phosphorylation of Syk in WT but not Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils. The above results indicate an indispensable role for Src family kinases in receptor-proximal Fc receptor signaling in neutrophils.

FcRγ deficiency recapitulates the phenotypes of Hck^−/−^Fgr^−/−^Lyn^−/−^ mutants
--------------------------------------------------------------------------------

The apparent role of Src family kinases in Fc receptor signaling prompted us to test the deficiency of FcRγ^−/−^ mice (which lack all activating Fcγ receptors; [@bib81]; [@bib2]) in more detail. In agreement with previous studies ([@bib30]; [@bib9]), FcRγ^−/−^ mice were completely protected from clinical signs of arthritis development in the K/B×N serum transfer model ([Fig. 10 A](#fig10){ref-type="fig"}; P = 0.0033 and 0.0039 for clinical score and ankle thickness, respectively; *n* = 5).

![**FcRγ deficiency phenocopies the deficiency of Src family kinases.** (A--C) K/B×N serum transfer arthritis was induced in intact WT and FcRγ^−/−^ mice as described in the [Fig. 1](#fig1){ref-type="fig"} legend, followed by analysis of the clinical disease course as described in [Fig. 1 A](#fig1){ref-type="fig"} (3 control and 5--7 arthritic mice per genotype from 3 independent experiments) or the quantification of leukocyte infiltration as described in [Fig. 4 (B and C](#fig4){ref-type="fig"}; 2--3 control and 6 arthritic mice per genotype from 3 independent experiments). (D and E) In vivo migration of neutrophils (PMN) and monocytes/macrophages (Mono/MΦ) determined using mixed bone marrow chimeras containing CD45.1-expressing WT and CD45.2-expressing FcRγ^−/−^ cells as described in [Fig. 5](#fig5){ref-type="fig"}. Each dot in D represents an individual mouse. E shows mean and SEM of relative migration. (D and E) Data were obtained from 6--8 mice per group from 3 independent experiments. (F) In vitro migration of WT and FcRγ^−/−^ neutrophils tested as described in [Fig. 5](#fig5){ref-type="fig"}. Data were obtained from 3 independent experiments. (G) Inflammatory mediator release from WT and FcRγ^−/−^ mice determined as described in [Fig. 6](#fig6){ref-type="fig"}. Data were obtained from 3--5 mice per group from 3 independent experiments. (H and I) Superoxide (H) or cytokine/chemokine/lipid mediator (I) release from immune complex-activated WT and FcRγ^−/−^ neutrophils from intact mice was determined as described in [Fig. 7](#fig7){ref-type="fig"}. Data were obtained from 4 (H) or 3 (I) independent experiments. (J) Bone marrow chimeras generated by transplanting FcRγ^−/−^ or CD45.1-expressing WT bone marrow cells mixed with Hck^−/−^Fgr^−/−^Lyn^−/−^ cells at varying ratios were subjected to K/B×N serum transfer arthritis as described in [Fig. 1](#fig1){ref-type="fig"}. Area under the curve (AUC) values for daily clinical scoring and ankle thickness measurements are shown in relation to the percentage of WT or FcRγ^−/−^ (i.e., non-Hck^−/−^Fgr^−/−^Lyn^−/−^) cells in the peripheral blood. Data represent results from 8--13 control and 28--32 arthritic serum-treated mice per group from 3 independent experiments. All error bars show SEM from the indicated number of mice or experiments.](JEM_20132496_Fig10){#fig10}

As shown in [Fig. 10 (B and C)](#fig10){ref-type="fig"}, no accumulation of neutrophils (P = 0.028; *n* = 6) or of monocytes/macrophages defined either as Ly6G^−^F4/80^+^ (P = 0.040; *n* = 6) or Ly6G^−^CD11b^+^ (P = 0.042; *n* = 6) cells could be observed in the ankle synovium in FcRγ^−/−^ mice. In contrast, in mixed bone marrow chimeras where WT hematopoietic cells were also present ([Fig. 10, D and E](#fig10){ref-type="fig"}), the FcRγ^−/−^ mutation did not affect the accumulation of neutrophils (P = 0.27; *n* = 8) or macrophages (P = 0.13; *n* = 8) in the synovial tissue (normalized to the percentage of circulating FcRγ^−/−^ neutrophils and monocytes, respectively). FcRγ^−/−^ neutrophils also migrated normally toward fMLP, LTB~4~, and MIP-2 in vitro ([Fig. 10 F](#fig10){ref-type="fig"}; 0.42 \< P \< 0.46; *n* = 3).

We also tested typical components of the inflammatory environment. FcRγ deficiency prevented the increase of IL-1β (P = 0.017; *n* = 5), KC (P = 0.026; *n* = 5), MCP-1 (P = 1.5 × 10^−5^; *n* = 4), MIP-1α (P = 0.023; *n* = 3), MIP-2 (P = 0.025; *n* = 4), and LTB~4~ (P = 0.016; *n* = 5) in the synovial tissue of K/B×N serum-treated mice ([Fig. 10 G](#fig10){ref-type="fig"} and not depicted). As reported before ([@bib28]), FcRγ^−/−^ neutrophils failed to release superoxide when plated on an immobilized IgG immune complex surface in vitro ([Fig. 10 H](#fig10){ref-type="fig"}; P = 7.4 × 10^−5^; *n* = 4). FcRγ deficiency also completely blocked the immune complex--induced release of IL-1β (P = 0.0020; *n* = 3), KC (P = 0.038; *n* = 3), MIP-1α (P = 0.031; *n* = 3), MIP-2 (P = 5.2 × 10^−4^; *n* = 3), and LTB~4~ (P = 0.013; *n* = 3) from neutrophils ([Fig. 10 I](#fig10){ref-type="fig"} and not depicted).

All the above experiments indicated that the Hck^−/−^Fgr^−/−^Lyn^−/−^ and the FcRγ^−/−^ mutations cause similar phenotypes in our in vitro and in vivo models of autoantibody-induced inflammatory reactions. To provide further evidence for the functional overlap between Src family kinases and FcRγ, we tested whether FcRγ^−/−^ hematopoietic cells can rescue arthritis development in Hck^−/−^Fgr^−/−^Lyn^−/−^ mutants. To this end, we generated mixed bone marrow chimeras carrying Hck^−/−^Fgr^−/−^Lyn^−/−^ hematopoietic system mixed with WT or FcRγ^−/−^ hematopoietic cells, and we tested arthritis development in those chimeras. As shown in [Fig. 10 J](#fig10){ref-type="fig"}, the presence of WT hematopoietic tissues in addition to Hck^−/−^Fgr^−/−^Lyn^−/−^ restored arthritis development. Obvious arthritis was clearly seen at ∼50% WT neutrophils in the circulation and the severity of arthritis further increased with increasing percentage of WT cells. In contrast, mixing Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ hematopoietic tissues did not result in any signs of arthritis development in the resulting chimeras at any ratio of the two genotypes in the circulating neutrophil pool. Collectively, the in vivo and in vitro phenotypes of Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ mutants are strikingly similar and FcRγ^−/−^ cells cannot restore arthritis development on the Hck^−/−^Fgr^−/−^Lyn^−/−^ background, suggesting a functional overlap between Src family kinases and Fcγ receptors.

DISCUSSION
==========

Our experiments have revealed complete protection of Hck^−/−^Fgr^−/−^Lyn^−/−^ mice from K/B×N serum transfer arthritis, autoantibody-induced skin blistering, and the reverse passive Arthus reaction ([Figs. 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Hck, Fgr, and Lyn were required in the hematopoietic compartment ([Fig. 1, E--H](#fig1){ref-type="fig"}) and showed significant functional overlap with each other ([Fig. 2](#fig2){ref-type="fig"}).

The overall phenotype of Hck^−/−^Fgr^−/−^Lyn^−/−^ mutants was very similar to that of β~2~ integrin--deficient (CD18^−/−^) mice ([@bib86]; [@bib41]; [@bib7]; [@bib56]). β~2~ integrins have long been known to mediate leukocyte migration to the site of inflammation ([@bib47]; [@bib73]; [@bib85]; [@bib74]). Indeed, we observed a complete defect of leukocyte infiltration into the synovial tissue of CD18^−/−^ animals ([Fig. 4](#fig4){ref-type="fig"}), and our mixed bone marrow chimeric experiments ([Fig. 5, A--G](#fig5){ref-type="fig"}) indicated, in agreement with a prior report ([@bib54]), that CD18^−/−^ myeloid cells had a cell-autonomous leukocyte migration defect. The similarities of the CD18^−/−^ and Hck^−/−^Fgr^−/−^Lyn^−/−^ phenotypes and the defective leukocyte infiltration in Hck^−/−^Fgr^−/−^Lyn^−/−^ mice ([Fig. 4](#fig4){ref-type="fig"}) suggested that Hck^−/−^Fgr^−/−^Lyn^−/−^ leukocytes have an intrinsic migration defect. However, Hck^−/−^Fgr^−/−^Lyn^−/−^ myeloid cells accumulated normally in the inflamed synovium in mixed bone marrow chimeras ([Fig. 5, A--G](#fig5){ref-type="fig"}) and showed no in vitro migration defects either ([Fig. 5, H and I](#fig5){ref-type="fig"}). In contrast, they failed to release inflammatory mediators when activated by immobilized immune complexes in vitro ([Fig. 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}). Therefore, the arthritis defect in Hck^−/−^Fgr^−/−^Lyn^−/−^ mice is likely due to the defective generation of an inflammatory environment rather than, as initially expected, to a cell-autonomous defect of β~2~ integrin--mediated leukocyte migration.

Our results, in agreement with prior studies ([@bib33]; [@bib5]; [@bib8]), indicate the existence of positive-feedback loops acting through the release of proinflammatory mediators (including IL-1β, neutrophil and monocyte/macrophage chemokines, and LTB~4~) from myeloid cells that attract further myeloid cells to the site of inflammation. β~2~ integrins and Src family kinases apparently function at different points of the feedback loop; whereas the former are required for the intrinsic migratory ability of leukocytes, the latter are involved in the release of proinflammatory mediators. Nevertheless, due to the nature of autoamplification loops, the CD18^−/−^ and the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutations both abrogate the entire inflammation process.

Although several prior reports proposed important roles for Src family kinases in in vitro ([@bib18]; [@bib72]) and in vivo ([@bib43]; [@bib46]; [@bib84]) migration of myeloid cells, several other studies came to the opposite conclusion ([@bib50]; [@bib92]; [@bib26]; [@bib89]). The interpretation of those studies is hindered by their limited scope ([@bib43]; [@bib72]), apparently contradicting results ([@bib46]; [@bib50]; [@bib92]), indications of indirect effects on leukocyte migration ([@bib84]), or defects seen only in unique in vitro assay systems ([@bib18]; [@bib72]). Though our studies confirm the overall requirement for Src family kinases in leukocyte migration to the site of inflammation ([Fig. 4](#fig4){ref-type="fig"}), we conclude that this is not due to an intrinsic migration defect but to defective generation of the inflammatory environment. We nevertheless believe that certain specific in vitro conditions (such as very narrow Transwell pore sizes, transmigration through tightly sealed endothelial monolayers, or truly two-dimensional assays) may favor leukocyte migration in a Src family--dependent manner. In this context, it is interesting to note that dasatinib, an inhibitor of Src family kinases, blocked human neutrophil migration in a two-dimensional Zigmond chamber assay but not in various three-dimensional assays ([@bib19]). Similarly, the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation partially reduced (but did not abrogate) neutrophil migration toward fMLP in a two-dimensional Zigmond chamber assay but not within a three-dimensional collagen gel (Barbara Walzog, personal communication). Further internally controlled in vivo experiments and detailed imaging studies, as well as analysis of other (e. g. microbial) chemotactic agents, will be needed to reveal the full spectrum of the contribution (or the lack of contribution) of Src family kinases to in vitro and in vivo migration of myeloid cells.

Several studies indicated a critical role for Src family kinases in β~2~ integrin--mediated neutrophil and macrophage activation ([@bib45]; [@bib48]; [@bib79]; [@bib20]). In agreement with those studies, both CD18^−/−^ and Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils failed to adhere to an ICAM1-coated surface (unpublished data). This is in sharp contrast to the normal β~2~ integrin--mediated migration of Hck^−/−^Fgr^−/−^Lyn^−/−^ neutrophils and macrophages ([Fig. 5](#fig5){ref-type="fig"}). Though those results suggest that Src family--mediated outside-in signaling of β~2~ integrins and the resulting cellular responses (e.g., cell spreading) are not required for β~2~ integrin--mediated leukocyte migration, additional studies will be needed to fully clarify that issue.

It should also be mentioned that a prior study revealed integrin-independent leukocyte migration in three-dimensional environments ([@bib37]). Though it would be tempting to speculate that the normal in vivo recruitment of Hck^−/−^Fgr^−/−^Lyn^−/−^ myeloid cells in mixed bone marrow chimeras is due to such integrin-independent mechanisms, the clear cell-autonomous requirement for CD18 ([Fig. 5, A--G](#fig5){ref-type="fig"}) indicates that this is not the case. Eosinophils comprised 19 ± 4% of circulating granulocytes but only 1.1 ± 0.7% of granulocytes in the synovial infiltrate (*n* = 5 mice per group), and eosinophil-deficient mice were even hyperresponsive in K/B×N serum transfer arthritis ([@bib6]). Despite some controversy ([@bib38]; [@bib93]; [@bib16]), our current understanding is that mast cells and basophils do not make a substantial contribution to autoantibody-induced arthritis either. Those points argue against a major contribution of eosinophils and mast cells/basophils to autoantibody-induced inflammation and the Hck^−/−^Fgr^−/−^Lyn^−/−^ phenotype.

Concerning how Src family kinases participate in the generation of the inflammatory environment, our biochemical studies ([Fig. 9, A--C](#fig9){ref-type="fig"}) suggest that the Hck^−/−^Fgr^−/−^Lyn^−/−^ mutation abrogates proximal signal transduction by activating Fcγ receptors. This is further supported by the similarities between the Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ mutants ([Fig. 10, A--I](#fig10){ref-type="fig"}) and the lack of rescue of the Hck^−/−^Fgr^−/−^Lyn^−/−^ arthritis phenotype by FcRγ^−/−^ hematopoietic cells ([Fig. 10 J](#fig10){ref-type="fig"}). As Fc receptors are also required for autoantibody-induced skin blistering disease ([@bib76], [@bib77]), this may also explain the protection of Hck^−/−^Fgr^−/−^Lyn^−/−^ mice in that model ([Fig. 3, A--C](#fig3){ref-type="fig"}).

Our results ([Figs. 7](#fig7){ref-type="fig"}--[10](#fig10){ref-type="fig"}) argue against prior assumptions that Src family kinases do not play a major role in Fc receptor signaling in myeloid cells ([@bib45]; [@bib17]; [@bib42]). In case of neutrophils, Lyn appears to compensate for the lack of the other two kinases in Hck^−/−^Fgr^−/−^ cells; therefore, a dramatic effect is only observed in Hck^−/−^Fgr^−/−^Lyn^−/−^ triple mutants ([Fig. 7, A and B](#fig7){ref-type="fig"}). In case of macrophages, the apparent contradiction may stem from a similar compensation by another Src family kinase (e. g. Src or Yes), or by different signals required for Fc receptor--mediated phagocytosis and responses to immobilized immune complexes.

An additional level of complexity may derive from a potential role for β~2~ integrins in immune complex--induced activation of myeloid cells. In agreement with a prior study ([@bib4]), we observed partial reduction of immune complex--induced functional responses of CD18^−/−^ neutrophils which, however, was not nearly as pronounced as the complete defect seen in Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ cells (unpublished data). Analysis of CD11a^−/−^ and CD11b^−/−^ mice revealed that the partial reduction of immune complex--induced neutrophil responses was mediated by Mac-1 (CD11b/CD18) rather than LFA-1 (CD11a/CD18), whereas, in agreement with prior studies ([@bib86]; [@bib54]), in vivo arthritis was primarily mediated by LFA-1 but not Mac-1 (unpublished data). In agreement with prior reports suggesting a negative role for Mac-1 in various neutrophil- and autoantibody-mediated inflammatory diseases ([@bib86]; [@bib70]), Mac-1--deficient (CD11b^−/−^) mice were even hyperresponsive in the K/B×N serum transfer model (unpublished data). Furthermore, although β~2~ integrin--mediated responses are primarily mediated by Hck and Fgr ([@bib45]; [@bib48]; [@bib79]), autoantibody-induced arthritis primarily relies on Hck and Lyn ([Fig. 2](#fig2){ref-type="fig"}). Those points together suggest that the amplification of immune complex--induced neutrophil responses by β~2~ integrins (primarily Mac-1) is unlikely to substantially contribute to the in vivo arthritis defect in Hck^−/−^Fgr^−/−^Lyn^−/−^ mice.

Collectively, our experiments have revealed a critical role for Src family kinases in various myeloid cell--mediated animal models of human disease. The role of Src family kinases was related to the immune complex--induced generation of an inflammatory microenvironment, revealing a so-far underestimated role for Src family kinases in the inflammatory response. Those results may contribute to the understanding, diagnosis, and therapy of major human diseases such as rheumatoid arthritis and inflammatory skin diseases.

MATERIALS AND METHODS
=====================

### Animals.

Mice homozygous for the *Hck*^tm1Hev^, *Fgr*^tm1Hev^, or *Lyn*^tm1Sor^ mutations (referred to as Hck^−/−^, Fgr^−/−^, or Lyn^−/−^ mice, respectively) were described before ([@bib44]; [@bib3]). Single, as well as combined double and triple knockout strains were maintained in homozygous form, except for the Hck/Lyn double mutation which was maintained in Hck^−/−^Lyn^+/−^ form due to the limited viability of Hck^−/−^Lyn^−/−^ mice ([@bib88]). It should be noted that although Hck^−/−^Lyn^−/−^ double knockout mice were of poor overall health and died within 2 mo after birth, Hck^−/−^Fgr^−/−^Lyn^−/−^ triple knockouts were apparently healthy and bred normally in homozygous form, indicating that the severe myeloproliferation reported in Hck^−/−^Lyn^−/−^ mice ([@bib88]) is somehow mediated by the Fgr kinase.

Complete CD18-deficient (*Itgb2*^tm2Bay/tm2Bay^, referred to as CD18*^−/−^*) mice ([@bib73]) were obtained from A. Beaudet (Baylor College of Medicine, Houston, TX). CD11a-deficient (*Itgal*^tm1Hogg/tm1Hogg^, referred to as CD11a^−/−^) mice ([@bib1]) were obtained from N. Hogg (Cancer Research UK, London, UK). CD11b-deficient (*Itgam*^tm1Myd/tm1Myd^, referred to as CD11b^−/−^) mice ([@bib10]) were purchased from The Jackson Laboratory. FcRγ-deficient (*Fcer1g*^tm1Rav/tm1Rav^, referred to as FcRγ^−/−^) mice ([@bib81]) were purchased from Taconic. Mice carrying the KRN T cell receptor transgene (Tg(TcraR28,TcrbR28)KRNDim; [@bib36]) were obtained from D. Mathis and C. Benoist (Harvard Medical School, Boston, MA) and maintained in heterozygous form by mating with C57BL/6 mice.

All transgenic mice were backcrossed to the C57BL/6 genetic background for at least 6 generations. Genotyping was performed by allele-specific PCR. WT control C57BL/6 mice were purchased from Charles River or the Hungarian National Institute of Oncology. NOD mice, as well as a congenic strain carrying the CD45.1 allele on the C57BL/6 genetic background (B6.SJL-*Ptprc*^a^), were purchased from The Jackson Laboratory. Mice were kept in individually sterile ventilated cages (Tecniplast) in a conventional facility. All animal experiments were approved by the Animal Experimentation Review Board of the Semmelweis University or the University of Pécs.

Bone marrow chimeras were generated by intravenous injection of unfractionated bone marrow cells into recipients carrying the CD45.1 allele on the C57BL/6 genetic background, which were lethally irradiated before by 11.5 Gy from a ^137^Cs source using a Gamma-Service Medical D1 irradiator. To test the role of Hck, Fgr, and Lyn in the nonhematopoietic compartment, Hck^−/−^Fgr^−/−^Lyn^−/−^ mice were irradiated and transplanted with CD45.1-expressing WT donor bone marrow cells. 3--6 wk after transplantation, peripheral blood samples were stained for Ly6G and CD45.2 and analyzed by flow cytometry (see below). Repopulation of the hematopoietic compartment by donor-derived cells was defined as the percentage of donor-derived cells in the Ly6G-positive granulocyte gate. Bone marrow chimeras were used 4--10 wk after the transplantation, except for Hck^−/−^Lyn^−/−^ chimeras which, due to their reported health issues ([@bib88]), were used 3--5 wk after transplantation.

Mixed bone marrow chimeras carrying Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ cells were generated as described above using a mixture of Hck^−/−^Fgr^−/−^Lyn^−/−^ and FcRγ^−/−^ donor bone marrow cells in the range of 1:3 to 3:1 ratios. The percentage of the two genotypes in the Ly6G-positive granulocyte gate in the resulting chimeras was tested by flow cytometry using an Alexa Fluor 647--conjugated antibody (clone 9E9; provided by F. Nimmerjahn, Erlangen, Germany) against mouse FcγRIV which is not expressed on FcRγ^−/−^ neutrophils ([@bib57]). Generation and analysis of mixed bone marrow chimeras for competitive migration experiments is described below.

### K/B×N serum transfer arthritis.

Mice carrying the KRN T cell receptor transgene on the C57BL/6 genetic background were mated with NOD mice to obtain transgene-positive (arthritic) K/B×N and transgene-negative (nonarthritic) B×N mice ([@bib36]; [@bib29]). The presence of the transgene was determined by allele-specific PCR and confirmed by phenotypic assessment. Blood was taken by retro-orbital bleeding and sera from arthritic and control mice were pooled separately.

Arthritis was induced by intraperitoneal injection of 300 µl K/B×N (arthritic) or B×N (control) serum into intact mice or bone marrow chimeras, followed by daily assessment of arthritis severity for 2 wk as previously described ([@bib29]). Visible clinical signs were scored on a 0--10 scale by two investigators blinded for the origin and treatment of the mice. Ankle thickness was measured by a spring-loaded caliper (Kroeplin). For histological analysis, mice were sacrificed 7 d after serum transfer, their ankles were fixed in formalin, decalcified, embedded in paraffin, sectioned at 5 µm thickness, and stained with hematoxylin and eosin ([@bib23]). Images were captured with an inverted microscope (DMI 6000B; Leica) using a 5× objective in transmitted light mode.

To assess articular function, mice were placed on a custom-made (Charles River Hungary) wire grid, slowly flipped, and the length of time the mice held on to the grid was recorded as previously described ([@bib29]). This test was performed 3 times daily during the period of 6--12 d after the serum injection. The obtained data were combined into "holding-on curves" for each mouse.

### In vivo imaging of ROS production.

A luminol chemiluminescence assay was used to detect in vivo MPO activity ([@bib22]). Mice were anaesthetized with 50 mg/kg pentobarbital sodium i.p. and injected i.p. with 150 mg/kg luminol sodium salt (Sigma-Aldrich) dissolved in PBS. Luminescence images were captured 10 min after the injection with an IVIS Lumina II imaging system (PerkinElmer) and processed using the Living Image software (PerkinElmer). Total radiance values (total photon flux/s) from standardized regions of interest of front and hind paws were used for quantitative analysis.

### Autoantibody-induced skin blistering model.

The murine model of the human autoantibody-induced blistering skin disease epidermolysis bullosa acquisita was triggered by systemic administration of antibodies against collagen VII ([@bib77]). GST fusion proteins containing the mCVIICr fragment of mouse collagen VII were expressed in *E. coli*, purified using GST affinity columns, and used to generate polyclonal antiserum in rabbits as previously described ([@bib11]). The IgG fraction of the antiserum was prepared using a Protein G Sepharose Fast Flow affinity column chromatography (GE Healthcare) as previously described ([@bib77]). The reactivity of the antibody preparation was tested using an ELISA with His-tagged mCVIICr fragment of murine collagen VII, as well as by indirect immunofluorescence on mouse skin sections as previously described ([@bib11]). Normal rabbit IgG (Sigma-Aldrich) was used as control.

15 mg pathogenic or control IgG per mouse was injected subcutaneously under isoflurane anesthesia on days 0 and 2, followed by 10 mg IgG/mouse on days 4, 6, and 8 (60 mg total IgG/mouse). The disease onset and progression was followed by clinical assessment and photodocumentation every two days. Scoring was based on the specific dermatological abnormalities (e.g., erythema, blister, crust) and the size of the affected skin area, with the latter determined using predefined percentages of the various areas of the skin of mice (e.g., one ear: 2.5%; snout: 5%; etc.). Antibody levels against collagen VII in blood samples at day 6 were determined by ELISA.

### Reverse passive Arthus reaction.

To trigger the cutaneous reverse passive Arthus reaction, WT or Hck^−/−^Fgr^−/−^Lyn^−/−^ mice were anesthetized by 2.5% tribromoethanol (Sigma-Aldrich) in PBS and injected intradermally into the right ear, with 20 µl rabbit polyclonal anti--chicken egg albumin (Ova; Sigma-Aldrich) whole serum diluted twofold in PBS. Similarly prepared normal rabbit serum (Sigma-Aldrich) was injected into the left ears as controls. This was immediately followed by i.v. injection of 0.4 mg ovalbumin (Sigma-Aldrich). 2 h later, the mice were injected i.v. with 80 MBq ^99m^Tc-labeled human serum albumin (prepared using the Albumon HSA ^99m^Tc labeling kit from Medi-Radiopharma, and ^99m^Tc-pertechnetate harvested from a Sorin/Drygen generator from Izotóp Intézet). After two more hours, mice were anesthetized with 10% urethan and the distribution of the radioactivity was detected using a NanoSPECT/CT Silver Upgrade SPECT/CT system (Mediso) along with a reference CT scan. Data were processed using the Fusion (Mediso) and VivoQuant (inviCRO) software. The radioactivity of the ears was normalized to that of the entire head area.

### In vivo analysis of myeloid cell migration.

In case of the K/B×N serum transfer model, the ankle or front paw area was flushed with 1 ml PBS supplemented with 10 mM EDTA (pH 7.5) and 20 mM HEPES (pH 7.4; Sigma) on day 4 to obtain a sample of synovial infiltrate. In case of the autoantibody-induced skin blistering model, the skin of the buccal area (which was most consistently affected by disease development) was isolated on day 7, minced, and digested with 28 U/ml Liberase and 10 mg/ml DNase I (both from Roche) in Ca^2+^ and Mg^2+^-containing Hank's balanced salt solution (HBSS; Invitrogen) supplemented with 20 mM Hepes, pH 7.4, for 1 h at 37°C with thorough stirring. The number and distribution of the myeloid cells in the resulting suspension was then determined by flow cytometry. Myeloid cell types were identified based on their typical forward and side scatter characteristics, as well as by positive staining of neutrophils for Ly6G (clone 1A8; BD), or positive staining of monocytes/macrophages for F4/80 (clone A3-1; AbD Serotec) or CD11b (clone M1/70; BD) within the Ly6G-negative gate.

A competitive migration assay in mixed bone marrow chimeras ([@bib29]) was also used to assess in vivo migration of myeloid cells. To this end, WT (C57BL/6), Hck^−/−^Fgr^−/−^Lyn^−/−^, CD18^−/−^, or FcRγ^−/−^ bone marrow cells (all carrying the CD45.2 allele) were mixed at varying ratios ranging from 1:4 to 4:1 with bone marrow cells from congenic mice expressing CD45.1 on the C57BL/6 genetic background. This mixed cell suspension was injected intravenously into lethally irradiated CD45.1-expressing recipient mice, giving rise to mixed bone marrow chimeras carrying CD45.2-expressing WT, CD18^−/−^, Hck^−/−^Fgr^−/−^Lyn^−/−^, or FcRγ^−/−^, along with CD45.1-expressing WT hematopoietic cells within the same animals. 5--8 wk after transplantation, the chimeras were subjected to K/B×N serum transfer arthritis and their synovial infiltrates were prepared as described above. The percentage of CD45.2-expressing cells within the above defined neutrophil and monocyte/macrophage gates from the synovial infiltrate and from peripheral blood samples were analyzed by flow cytometry as described above, with an additional staining for CD45.2 (clone 104; BD).

Relative migration (accumulation) of the CD45.2-positive neutrophils or monocytes/macrophages (relative to the CD45.1-expressing WT cells) was calculated as follows:$$\text{relative\ migration} = \frac{\left( \frac{\text{percentage\ of\ CD45.2\ cells\ in\ synovial\ infiltrate}}{\text{percentage\ of\ CD45.2\ cells\ in\ blood}} \right)}{\left( \frac{\text{percentage\ of\ CD45.1\ cells\ in\ synovial\ infiltrate}}{\text{percentage\ of\ CD45.1\ cells\ in\ blood}} \right)}$$

### Isolation and activation of neutrophils, monocytes, and macrophages.

Mouse neutrophils were isolated from the bone marrow of the femurs and tibias of intact mice by hypotonic lysis followed by Percoll (GE Healthcare) gradient centrifugation using sterile and endotoxin-free reagents as previously described ([@bib51]). Cells were kept at room temperature in Ca^2+^- and Mg^2+^-free medium until use (usually less than 30 min) and prewarmed to 37°C before activation. Neutrophil assays were performed at 37°C in HBSS supplemented with 20 mM Hepes, pH 7.4.

Mouse bone marrow-derived macrophages were obtained by culturing bone marrow cells from intact mice in α-MEM (Sigma) complemented with 10% FCS (Invitrogen), 2 mM [l]{.smallcaps}-glutamine, antibiotics, 10 mM HEPES (all from Sigma-Aldrich), and 10% conditioned medium from CMG 14--12 cells as a source of recombinant murine M-CSF ([@bib32]) for 8--10 d on bacterial Petri dishes with media changes every 2--3 d. Cells were suspended by 5 mM EDTA, washed and serum-starved for 2 h before the experiments.

Mouse monocytes were isolated from the bone marrow of femurs and tibias of intact mice using a CD115 MicroBead kit (Miltenyi Biotec), followed by magnetic separation on LS columns (Miltenyi Biotec) according to the manufacturer's instructions. Sample purity was \>95% as tested by flow cytometry using F4/80 and Ly6G staining. In vitro monocyte assays were performed in HBSS supplemented with 20 mM Hepes, pH 7.4. Cells were kept at 4°C throughout the separation and were prewarmed to 37°C before the assay.

To obtain immobilized immune complex--coated surfaces, human serum albumin (HSA; Sigma-Aldrich) was either bound directly to regular or luminometric Nunc MaxiSorp F96 (Thermo Fisher Scientific) plates or covalently linked to poly-[l]{.smallcaps}-lysine--coated 6-cm tissue culture dishes and then treated with anti-HSA IgG (Sigma-Aldrich) as previously described ([@bib28]). For the analysis of proinflammatory mediator release, 100 µl aliquots of 4 × 10^6^/ml neutrophils or 500 µl aliquots of 3 × 10^6^/ml macrophages suspended in HBSS supplemented with 20 mM Hepes, pH 7.4, were plated on immobilized immune complex surfaces in 96-well ELISA plates or 24-well tissue culture plates, respectively, stimulated for 6 or 24 h, respectively, and the inflammatory mediator concentration of the supernatant was determined as described below. For the analysis of LTB~4~ production, 100 µl aliquots of 4 × 10^6^/ml neutrophils or 500 µl aliquots of 3 × 10^6^/ml macrophages suspended in DMEM (Sigma-Aldrich) were plated on immobilized immune complex surfaces in 96-well ELISA plates or 24-well tissue culture plates, respectively, for 1 h and the LTB~4~ concentration of the cell-free supernatant was measured as described below. Superoxide release by neutrophils was followed by a cytochrome *c* reduction test from 100 µl aliquots of 4 × 10^6^/ml cells plated on immune complex--coated surfaces in 96-well ELISA plates as previously described ([@bib56]). To test ROS production by macrophages, 100 µl aliquots of 3 × 10^6^/ml cells were plated on immune complex--coated surfaces in 96-well luminometric ELISA plates in the presence of 50 µg/ml lucigenin (Sigma-Aldrich), and the chemiluminescence of the samples was followed by a luminometer (Mithras LB 940; Berthold).

In vitro migration of neutrophils and monocytes was tested using a Transwell (Corning) assay with inserts of 3 µm pore size coated with human fibrinogen as previously described ([@bib29]). 100 ng/ml MIP-2, 100 ng/ml MCP-1, 100 ng/ml MIP-1α (all from PeproTech) or 50 ng/ml LTB~4~ (Santa Cruz Biotechnology, Inc.) was used as chemoattractants. Transmigrated cells were counted using a Neubauer chamber (monocytes) or measured by an acid phosphatase assay (neutrophils; [@bib29]).

To test neutrophil adhesion to ICAM-1, 96-well ELISA plates were coated with 10 µg/ml recombinant mouse ICAM-1 (Fc chimera; R&D Systems) in 50 mM carbonate buffer, pH 9.6, and blocked with 10% FCS (Invitrogen). 4 × 10^6^/ml neutrophils were plated on the ICAM-1--coated surface, stimulated with 50 ng/ml mouse TNF (PeproTech), and incubated for 1 h. The adhesion of the cells was then determined using an acid phosphatase assay ([@bib29]).

### Analysis of inflammatory mediators.

The release of inflammatory mediators was tested from the cell-free supernatants of synovial infiltrates or of in vitro stimulated neutrophils or macrophages. Semiquantitative analysis of the level of inflammation-related chemokines and cytokines was performed using a mouse cytokine antibody array kit (Panel A from R&D Systems) according to the manufacturer's instructions and quantified using densitometry of x-ray films. The levels of IL-1β, KC, MCP-1, MIP-1α, and MIP-2, as well as of the lipid mediator LTB~4~, were further tested by commercial ELISA kits (R&D Systems) according to the manufacturer's instructions.

### Biochemical studies.

For analysis of intracellular signaling, 8 × 10^6^ neutrophils in 1 ml assay buffer were plated on immune complex-covered 6-cm tissue culture dishes and incubated for 10 min at 37°C. The reaction was stopped on ice and the cells (adherent and nonadherent combined) were lysed in 100 mM NaCl, 30 mM Na-Hepes, pH 7.4, 20 mM NaF, 1 mM Na-EGTA, 1% Triton X-100, and 1 mM benzamidine, freshly supplemented with 0.1 U/ml Aprotinin, 1:100 Mammalian Protease Inhibitor Cocktail, 1:100 Phosphatase Inhibitor Cocktail 2, and 1 mM PMSF (all from Sigma-Aldrich). After removal of insoluble material, lysates were either boiled in sample buffer or processed for immunoprecipitation or GST pulldown assays. Immunoprecipitation of Syk was performed using a rabbit polyclonal anti-murine Syk antiserum ([@bib82]; provided by V. Tybulewicz, National Institute for Medical Research, London, UK), followed by capturing with a combination of Protein A--Sepharose (Invitrogen) and Protein G--Agarose (Invitrogen) as previously described ([@bib49], [@bib52], [@bib53]). GST-Syk(SH2)~2~ pulldown experiments were performed as previously described ([@bib52], [@bib53]).

Whole cell lysates, immunoprecipitates, and GST-Syk(SH2)~2~ pulldown samples were run on SDS-PAGE and immunoblotted using antibodies against phosphotyrosine (4G10; Millipore), the FcRγ-chain (Millipore), or Syk (using the precipitating antibody), followed by peroxidase-labeled secondary antibodies (GE Healthcare). The signal was developed using the ECL system (GE Healthcare) and exposed to x-ray film.

### Presentation of the data and statistical analysis.

Experiments were performed the indicated number of times. Quantitative graphs show mean and SEM from all independent in vitro experiments or from all individual mice from the indicated number of experiments. In case of kinetic assays, the area under the curve (AUC) calculated after subtraction of the zero time point values has been used for further calculations and analyses. For the determination of statistical significance, the response of each genotype was calculated by subtracting the control values from that of the stimulated samples, followed by normalization to the WT response within each experiment. A two-tailed Student's *t* test with unequal variance was then performed on all normalized samples to determine whether the response in a given mutant strain was statistically different from that in the WT samples (indicated by p-values in the text). P-values \<0.05 were considered statistically significant.

### Online supplemental material.

Table S1 includes the densitometric analysis of mouse cytokine arrays. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20132496/DC1>.
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